165 related articles for article (PubMed ID: 25601942)
21. Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.
Maeki T; Tajima S; Kyaw AK; Matsumoto F; Miura K; Yamashita A; Yoshikawa A; Negishi K; Noguchi Y; Tadokoro K; Abe K; Taruya J; Koh J; Ito H; Ikegaya A; Abe F; Wada M; Nishigata T; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Morita K; Lim CK; Saijo M
Jpn J Infect Dis; 2018 Sep; 71(5):360-364. PubMed ID: 29962489
[TBL] [Abstract][Full Text] [Related]
22. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
23. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study.
Vu TD; Nguyen QD; Tran HTA; Bosch-Castells V; Zocchetti C; Houillon G
Int J Infect Dis; 2018 Jan; 66():137-142. PubMed ID: 29081368
[TBL] [Abstract][Full Text] [Related]
25. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Lobigs M; Pavy M; Hall RA; Lobigs P; Cooper P; Komiya T; Toriniwa H; Petrovsky N
J Gen Virol; 2010 Jun; 91(Pt 6):1407-17. PubMed ID: 20130134
[TBL] [Abstract][Full Text] [Related]
26. Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine.
Fan YC; Chen JM; Lin JW; Chen YY; Wu GH; Su KH; Chiou MT; Wu SR; Yin JH; Liao JW; Chang GJ; Chiou SS
Sci Rep; 2018 May; 8(1):7481. PubMed ID: 29748549
[TBL] [Abstract][Full Text] [Related]
27. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Feroldi E; Pancharoen C; Kosalaraksa P; Chokephaibulkit K; Boaz M; Meric C; Hutagalung Y; Bouckenooghe A
Pediatr Infect Dis J; 2014 Jun; 33(6):643-9. PubMed ID: 24717964
[TBL] [Abstract][Full Text] [Related]
28. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
Cramer JP; Jelinek T; Paulke-Korinek M; Reisinger EC; Dieckmann S; Alberer M; Bühler S; Bosse D; Meyer S; Fragapane E; Costantini M; Pellegrini M; Lattanzi M; Dovali C
J Travel Med; 2016 Mar; 23(3):. PubMed ID: 26994987
[TBL] [Abstract][Full Text] [Related]
29. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Clin Infect Dis; 2013 Jan; 56(2):267-70. PubMed ID: 23074319
[TBL] [Abstract][Full Text] [Related]
30. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
31. Duration of seroprotection of the live attenuated SA-14-14-2 Japanese encephalitis vaccine in children in India.
Preethi L; Alina MS; Chandran L; Asvin S; Jagadeesan M; Vijayakumar TM; Chitra V; Pandey AK; Reddy MM; Misra BR; Kant R; Bhukya PL; Deshpande GR; Abraham P; Sapkal G; Zaman K
J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36495206
[TBL] [Abstract][Full Text] [Related]
32. Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan.
Huang LM; Lin TY; Chiu CH; Chiu NC; Chen PY; Yeh SJ; Boaz M; Hutagalung Y; Bouckenooghe A; Feroldi E
Vaccine; 2014 Sep; 32(41):5363-9. PubMed ID: 24631095
[TBL] [Abstract][Full Text] [Related]
33. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.
Fan YC; Chen JM; Chen YY; Lin JW; Chiou SS
Vet Microbiol; 2013 May; 163(3-4):248-56. PubMed ID: 23415032
[TBL] [Abstract][Full Text] [Related]
34. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M
Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.
Khan SA; Kakati S; Dutta P; Chowdhury P; Borah J; Topno R; Jadhav SM; Mohapatra PK; Mahanta J; Gupte MD
Indian J Med Res; 2016 Dec; 144(6):886-892. PubMed ID: 28474625
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.
Jelinek T; Cramer JP; Dieckmann S; Hatz C; Paulke-Korinek M; Alberer M; Reisinger EC; Costantini M; Gniel D; Bosse D; Lattanzi M
Travel Med Infect Dis; 2015; 13(3):241-50. PubMed ID: 26005163
[TBL] [Abstract][Full Text] [Related]
38. Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
Bouckenooghe A; Bailleux F; Feroldi E
Hum Vaccin Immunother; 2019; 15(1):72-79. PubMed ID: 30230947
[TBL] [Abstract][Full Text] [Related]
39. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study.
Tandale BV; Khan SA; Kushwaha KP; Rahman H; Gore MM;
J Infect Public Health; 2018; 11(5):713-719. PubMed ID: 29703709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
